Brief: China NT Pharma Proposes Share Consolidation
14/05/2024 15:52
May 14 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* PROPOSES TO CONSOLIDATE EVERY 10 ISSUED AND UNISSUED
SHARES OF
PAR VALUE OF US$0.00000008 INTO 1 SHARE OF US$0.0000008 EACH
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY